経口固形剤受託製造の世界市場レポート 2025年

経口固形剤受託製造市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.6%で、568億9,000万米ドルに成長します。予測期間における成長の背景には、製薬企業によるアウトソーシングの増加、ドラッグデリバリー技術の進歩、医薬品開発活動の活発化などがあります。予測期間における主な動向としては、ドラッグデリバリー技術の進歩、3Dプリンティングの統合、放出制御技術の進歩などが挙げられます。

ジェネリック医薬品に対する需要の急増が、今後数年間の経口固形剤受託製造市場の成長を牽引すると予想されます。ジェネリック医薬品は、用量、強さ、安全性、性能、品質、使用目的において先発医薬品と生物学的に同等な医薬品です。ジェネリック医薬品の需要増は、特許切れ、コスト抑制の取り組み、規制上のインセンティブ、ヘルスケアへのアクセス拡大への取り組みなどの要因によって促進されています。経口固形剤受託製造は、業務効率の向上、コスト削減、高品質の生産、市場への製品導入の迅速化など、受託製造業者の能力を活用することで、ジェネリック医薬品の生産と流通を促進する上で極めて重要な役割を果たしています。例えば、2022年に米国食品医薬品局（FDA）は、米国内の処方箋の91％がジェネリック医薬品で満たされ、FDAが承認したジェネリック医薬品は3万2,000品目以上に上ると推定しています。その結果、ジェネリック医薬品の需要が経口固形剤受託製造市場の成長を促進しています。

経口固形剤受託製造市場の主なプレーヤーは、市場での地位を強化するために、連続製造ラインなどの革新的なソリューションの開発に注力しています。連続製造ラインとは、医薬品やその他の製品を製造するための連続製造プロセスを採用した製造施設やシステムのことを指します。例えば、2023年1月、中国の製薬会社であるWuXi STA社は、同社初の経口固形医薬品の連続製造ラインを稼働させました。この最新鋭の設備は、医薬品製造における大きな進歩を象徴しており、連続製造の原理を活用して医薬品製造工程の効率、品質、柔軟性を向上させています。この機敏性の向上により、製造スケジュールが合理化され、ダウンタイムが最小限に抑えられるため、最終的には患者への必要不可欠な医薬品の供給が迅速化されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界経口固形剤受託製造PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の経口固形剤受託製造市場：成長率分析
• 世界の経口固形剤受託製造市場の実績：規模と成長, 2019-2024
• 世界の経口固形剤受託製造市場の予測：規模と成長, 2024-2029, 2034F
• 世界経口固形剤受託製造総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の経口固形剤受託製造市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• カプセル
• 粉末
• 顆粒
• その他の製品タイプ
• 世界の経口固形剤受託製造市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品開発
• 充填仕上げ製品の製造
• 医薬品有効成分（API）製造
• 包装とラベル
• その他の用途
• 世界の経口固形剤受託製造市場治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 心血管疾患
• 代謝障害
• 神経疾患
• 感染症
• 消化器疾患
• その他の治療領域
• 世界の経口固形剤受託製造市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大企業
• 中小企業
• 世界の経口固形剤受託製造市場錠剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 圧縮錠
• 発泡錠
• チュアブル錠
• コーティング錠（腸溶錠、フィルムコーティング錠）
• 徐放錠または放出制御錠
• 世界の経口固形剤受託製造市場カプセルの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハードゼラチンカプセル
• ソフトジェルカプセル
• ベジタリアンカプセル
• 液体入りカプセル
• 遅延放出カプセル
• 世界の経口固形剤受託製造市場粉末の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口懸濁液用粉末
• 直接圧縮用粉末
• 混合またはブレンド用の粉末
• 瞬間溶解粉末
• 世界の経口固形剤受託製造市場顆粒の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接圧縮用顆粒
• 錠剤用顆粒
• 発泡性顆粒
• 遅延放出または制御放出顆粒
• 世界の経口固形剤受託製造市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ロゼンジ
• 口腔ストリップ
• 口腔薄膜
• 発泡錠または顆粒

第7章 地域別・国別分析

• 世界の経口固形剤受託製造市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の経口固形剤受託製造市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 経口固形剤受託製造市場：競合情勢
• 経口固形剤受託製造市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Siemens Healthineers AG
• Evonik Industries AG
• Teva Pharmaceutical Industries Ltd.
• Lonza Group AG
• Catalent Inc.
• Patheon Pharma Services
• Fareva Holding SA
• Piramal Enterprises Limited
• Hetero Drugs Limited
• Siegfried Holding AG
• Recipharm AB
• Almac Group Limited
• Aenova Holding GmbH
• Jubilant Pharmova Limited
• Cambrex Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 経口固形剤受託製造市場2029：新たな機会を提供する国
• 経口固形剤受託製造市場2029：新たな機会を提供するセグメント
• 経口固形剤受託製造市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Oral solid dosage contract manufacturing involves outsourcing the production of oral solid dosage forms of pharmaceuticals to third-party manufacturers. This strategy enables pharmaceutical companies to concentrate on their core activities, such as research, development, and marketing, while utilizing the expertise and capabilities of contract manufacturing organizations (CMOs) to efficiently produce high-quality oral solid dosage pharmaceuticals.

The main product types in oral solid dosage contract manufacturing include tablets, capsules, powders, granules, and other forms. Tablets are small, solid masses of medicine containing an active drug and excipients. The services offered encompass drug product development, fill-finish product manufacturing, API manufacturing, packaging and labeling, and other applications. The therapeutic areas covered include oncology, cardiovascular diseases, metabolic disorders, neurological disorders, infectious diseases, gastrointestinal diseases, and other therapeutic areas. The end users of these services are large companies, as well as medium and small companies.

The oral solid dosage contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides oral solid dosage contract manufacturing market statistics, including oral solid dosage contract manufacturing industry global market size, regional shares, competitors with a oral solid dosage contract manufacturing market share, detailed oral solid dosage contract manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the oral solid dosage contract manufacturing industry. This oral solid dosage contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral solid dosage contract manufacturing market size has grown strongly in recent years. It will grow from $39.39 billion in 2024 to $42.51 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to the growing global population, prevalence of chronic diseases, and rise in focus on research and development.

The oral solid dosage contract manufacturing market size is expected to see strong growth in the next few years. It will grow to $56.89 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing outsourcing by pharmaceutical companies, advancements in drug delivery technology, and increasing drug development activities. Major trends in the forecast period include advancements in drug delivery technology, integration of 3D printing, and advancements in controlled-release technologies.

The surge in demand for generic drugs is anticipated to drive the growth of the oral solid dosage contract manufacturing market in the coming years. Generic drugs are medications that are bioequivalent to brand-name drugs in dosage, strength, safety, performance, quality, and intended use. The increasing demand for generic drugs is fueled by factors such as patent expirations, cost containment initiatives, regulatory incentives, and efforts to expand access to healthcare. Oral solid dosage contract manufacturing plays a pivotal role in facilitating the production and distribution of generic drugs by leveraging the capabilities of contract manufacturers to enhance operational efficiency, reduce costs, ensure high-quality production, and expedite the introduction of products to the market. For example, in 2022, the Food and Drug Administration (FDA) estimated that 91% of all prescriptions in the USA were filled with generic drugs, with over 32,000 generic drugs approved by the FDA. Consequently, the demand for generic drugs propels the growth of the oral solid dosage contract manufacturing market.

Key players in the oral solid dosage contract manufacturing market are concentrating on developing innovative solutions, such as continuous manufacturing lines, to fortify their position in the market. A continuous manufacturing line refers to a production facility or system that employs continuous manufacturing processes to produce pharmaceuticals or other products. For instance, in January 2023, WuXi STA, a pharmaceutical company based in China, inaugurated its first continuous manufacturing line for oral solid pharmaceutical products. This state-of-the-art facility represents a significant advancement in pharmaceutical production, harnessing continuous manufacturing principles to enhance efficiency, quality, and flexibility in drug manufacturing processes. This enhanced agility streamlines production timelines and minimizes downtime, ultimately expediting the delivery of essential medications to patients.

In August 2022, Catalent Inc., a US-based pharmaceutical company, completed the acquisition of Metrics Contract Services for $475 million. Through this acquisition, Catalent seeks to broaden its capabilities in the development and manufacturing of oral solid dosage forms. Metrics Contract Services is a US-based full-service contract development and manufacturing organization (CDMO) specializing in oral dosage forms.

Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation

Asia Pacific was the largest region in the oral solid dosage contract manufacturing market in 2024. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral solid dosage contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral solid dosage contract manufacturing market consists of revenues earned by entities by providing services such as formulation development, analytical and stability testing, and quality assurance and control. The market value includes the value of related goods sold by the service provider or included within the service offering. The oral solid dosage contract manufacturing market also consists of sales of orally disintegrating tablets (ODTS), lozenges, and chewing gums. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Solid Dosage Contract Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral solid dosage contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral solid dosage contract manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral solid dosage contract manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tablets; Capsules; Powders; Granules; Other Product Types
• 2) By Service: Drug Product Development; Fill Finish Product Manufacturing; API Manufacturing; Packaging And Labelling; Other Applications
• 3) By Therapeutic Area: Oncology; Cardiovascular Diseases; Metabolic Disorders; Neurological Disorders; infectious Diseases; Gastrointestinal Diseases; Other Therapeutic Areas
• 4) By End User: Large Size Companies; Medium And Small Size Companies
• Subsegments:
• 1) By Tablets: Compressed Tablets; Effervescent Tablets; Chewable Tablets; Coated Tablets (Enteric, Film Coated); Sustained Or Controlled Release Tablets
• 2) By Capsules: Hard Gelatin Capsules; Soft Gel Capsules; Vegetarian Capsules; Liquid-Filled Capsules; Delayed Release Capsules
• 3) By Powders: Powders For Oral Suspension; Powders For Direct Compression; Powders For Mixing Or Blending; Instant Dissolving Powders
• 4) By Granules: Granules For Direct Compression; Granules For Tabletting; Effervescent Granules; Delayed Or Controlled Release Granules
• 5) By Other Product Types: Lozenges; Oral Strips; Oral Thin Films; Effervescent Tablets Or Granules
• Companies Mentioned: Pfizer Inc.; Takeda Pharmaceutical Company Limited; Gilead Sciences Inc.; Amgen Inc.; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oral Solid Dosage Contract Manufacturing Market Characteristics

3. Oral Solid Dosage Contract Manufacturing Market Trends And Strategies

4. Oral Solid Dosage Contract Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Oral Solid Dosage Contract Manufacturing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oral Solid Dosage Contract Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oral Solid Dosage Contract Manufacturing Market Growth Rate Analysis
• 5.4. Global Oral Solid Dosage Contract Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oral Solid Dosage Contract Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oral Solid Dosage Contract Manufacturing Total Addressable Market (TAM)

6. Oral Solid Dosage Contract Manufacturing Market Segmentation

• 6.1. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Powders
• Granules
• Other Product Types
• 6.2. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Product Development
• Fill Finish Product Manufacturing
• Active Pharmaceutical Ingredient (API) Manufacturing
• Packaging And Labelling
• Other Applications
• 6.3. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiovascular Diseases
• Metabolic Disorders
• Neurological Disorders
• Infectious Diseases
• Gastrointestinal Diseases
• Other Therapeutic Areas
• 6.4. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Large Size Companies
• Medium And Small Size Companies
• 6.5. Global Oral Solid Dosage Contract Manufacturing Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Compressed Tablets
• Effervescent Tablets
• Chewable Tablets
• Coated Tablets (Enteric, Film Coated)
• Sustained Or Controlled Release Tablets
• 6.6. Global Oral Solid Dosage Contract Manufacturing Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hard Gelatin Capsules
• Soft Gel Capsules
• Vegetarian Capsules
• Liquid-Filled Capsules
• Delayed Release Capsules
• 6.7. Global Oral Solid Dosage Contract Manufacturing Market, Sub-Segmentation Of Powders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powders For Oral Suspension
• Powders For Direct Compression
• Powders For Mixing Or Blending
• Instant Dissolving Powders
• 6.8. Global Oral Solid Dosage Contract Manufacturing Market, Sub-Segmentation Of Granules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Granules For Direct Compression
• Granules For Tabletting
• Effervescent Granules
• Delayed Or Controlled Release Granules
• 6.9. Global Oral Solid Dosage Contract Manufacturing Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lozenges
• Oral Strips
• Oral Thin Films
• Effervescent Tablets Or Granules

7. Oral Solid Dosage Contract Manufacturing Market Regional And Country Analysis

• 7.1. Global Oral Solid Dosage Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oral Solid Dosage Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market

• 8.1. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oral Solid Dosage Contract Manufacturing Market

• 9.1. China Oral Solid Dosage Contract Manufacturing Market Overview
• 9.2. China Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oral Solid Dosage Contract Manufacturing Market

• 10.1. India Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oral Solid Dosage Contract Manufacturing Market

• 11.1. Japan Oral Solid Dosage Contract Manufacturing Market Overview
• 11.2. Japan Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oral Solid Dosage Contract Manufacturing Market

• 12.1. Australia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oral Solid Dosage Contract Manufacturing Market

• 13.1. Indonesia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oral Solid Dosage Contract Manufacturing Market

• 14.1. South Korea Oral Solid Dosage Contract Manufacturing Market Overview
• 14.2. South Korea Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oral Solid Dosage Contract Manufacturing Market

• 15.1. Western Europe Oral Solid Dosage Contract Manufacturing Market Overview
• 15.2. Western Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oral Solid Dosage Contract Manufacturing Market

• 16.1. UK Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oral Solid Dosage Contract Manufacturing Market

• 17.1. Germany Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oral Solid Dosage Contract Manufacturing Market

• 18.1. France Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oral Solid Dosage Contract Manufacturing Market

• 19.1. Italy Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oral Solid Dosage Contract Manufacturing Market

• 20.1. Spain Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oral Solid Dosage Contract Manufacturing Market

• 21.1. Eastern Europe Oral Solid Dosage Contract Manufacturing Market Overview
• 21.2. Eastern Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oral Solid Dosage Contract Manufacturing Market

• 22.1. Russia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oral Solid Dosage Contract Manufacturing Market

• 23.1. North America Oral Solid Dosage Contract Manufacturing Market Overview
• 23.2. North America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oral Solid Dosage Contract Manufacturing Market

• 24.1. USA Oral Solid Dosage Contract Manufacturing Market Overview
• 24.2. USA Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oral Solid Dosage Contract Manufacturing Market

• 25.1. Canada Oral Solid Dosage Contract Manufacturing Market Overview
• 25.2. Canada Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oral Solid Dosage Contract Manufacturing Market

• 26.1. South America Oral Solid Dosage Contract Manufacturing Market Overview
• 26.2. South America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oral Solid Dosage Contract Manufacturing Market

• 27.1. Brazil Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oral Solid Dosage Contract Manufacturing Market

• 28.1. Middle East Oral Solid Dosage Contract Manufacturing Market Overview
• 28.2. Middle East Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oral Solid Dosage Contract Manufacturing Market

• 29.1. Africa Oral Solid Dosage Contract Manufacturing Market Overview
• 29.2. Africa Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oral Solid Dosage Contract Manufacturing Market Competitive Landscape And Company Profiles

• 30.1. Oral Solid Dosage Contract Manufacturing Market Competitive Landscape
• 30.2. Oral Solid Dosage Contract Manufacturing Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Oral Solid Dosage Contract Manufacturing Market Other Major And Innovative Companies

• 31.1. Siemens Healthineers AG
• 31.2. Evonik Industries AG
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Lonza Group AG
• 31.5. Catalent Inc.
• 31.6. Patheon Pharma Services
• 31.7. Fareva Holding SA
• 31.8. Piramal Enterprises Limited
• 31.9. Hetero Drugs Limited
• 31.10. Siegfried Holding AG
• 31.11. Recipharm AB
• 31.12. Almac Group Limited
• 31.13. Aenova Holding GmbH
• 31.14. Jubilant Pharmova Limited
• 31.15. Cambrex Corporation

32. Global Oral Solid Dosage Contract Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oral Solid Dosage Contract Manufacturing Market

34. Recent Developments In The Oral Solid Dosage Contract Manufacturing Market

35. Oral Solid Dosage Contract Manufacturing Market High Potential Countries, Segments and Strategies

• 35.1 Oral Solid Dosage Contract Manufacturing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oral Solid Dosage Contract Manufacturing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oral Solid Dosage Contract Manufacturing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer